Advanced Biomed Statistics
Total Valuation
ADVB has a market cap or net worth of $109.38 million. The enterprise value is $107.14 million.
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
ADVB has 21.88 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 21.88M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 45.86 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.13 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 74,236.61 |
Financial Efficiency
Return on equity (ROE) is -199.20% and return on invested capital (ROIC) is -177.05%.
Return on Equity (ROE) | -199.20% |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | -177.05% |
Revenue Per Employee | n/a |
Profits Per Employee | -$125,028 |
Employee Count | 38 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -4.75M |
Pretax Income | -4.75M |
Net Income | -4.75M |
EBITDA | -4.44M |
EBIT | -4.75M |
Earnings Per Share (EPS) | -$0.22 |
Full Income Statement Balance Sheet
The company has $2.53 million in cash and $299,219 in debt, giving a net cash position of $2.23 million or $0.10 per share.
Cash & Cash Equivalents | 2.53M |
Total Debt | 299,219 |
Net Cash | 2.23M |
Net Cash Per Share | $0.10 |
Equity (Book Value) | 2.39M |
Book Value Per Share | 0.11 |
Working Capital | 1.03M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$4.67 million and capital expenditures -$709,910, giving a free cash flow of -$5.38 million.
Operating Cash Flow | -4.67M |
Capital Expenditures | -709,910 |
Free Cash Flow | -5.38M |
FCF Per Share | -$0.25 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |